DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo


company name or ticker

EnteroMedics: A Preview of the Weight-Loss Zapper FDA Panel

Cramer's Lightning Round - Trains Are On The Rails (6/11/14)

Why Orexigen Therapeutics, United Natural Foods, and United Continental Holdings Tumbled Today

Stocks tumbled today as fears of a global slowdown hit investor confidence. These three stocks also faced company-specific challenges.

Orexigen Irony: No VIVUS Bounce

Biotech Stock Roundup: Biogen Hemophilia Drug Approved, Ariad & Halozyme Clinical Hold Lifted - Anal

Biotech Stock Roundup: Biogen Hemophilia Drug Approved, Ariad & Halozyme Clinical Hold Lifted - Analyst Blog

Mid-Afternoon Market Update: ULTA Salon Remains Steady After Strong Results; Orexigen Still Down 15%

Mid-Afternoon Market Update: ULTA Salon Remains Steady After Strong Results; Orexigen Still Down 15%

Why Orexigen Therapeutics Inc. Shares Were Throttled

Orexigen shares get hammered after the FDA pushes back a key decision date. Find out what this means for shareholders.

Orexigen (OREX) Enters Overbought Territory - Tale of the Tape

Why Orexigen Therapeutics is Falling Today

Orexigen Therapeutics announced today that the regulatory decision for its obesity medication Contrave will be delayed by three months, causing shares to crater in early trading. Are investors overreacting?
See More Articles...